Read by QxMD icon Read

CKD prevalence,incidence in Africa

Nomandla Daphne Madala, Thozama Dubula, Alain Guy Honoré Assounga, Saraladevi Naicker
BACKGROUND: Recent evidence that hyperuricemia is associated with incident chronic kidney disease (CKD) provides a potential therapeutic target for CKD that has not been explored in Africans. With hyperuricemia and gout increasing globally, we sought to determine their prevalence in South Africans with varying kidney function levels. METHODS: This was a cross-sectional study of ambulatory adult patients presenting at a General Internal Medicine Outpatients Clinic between September 2012 and March 2014...
December 2017: Metabolic Syndrome and related Disorders
Mazou N Temgoua, Celestin Danwang, Valirie Ndip Agbor, Jean Jacques Noubiap
INTRODUCTION: Chronic kidney disease (CKD) is a global public health problem, with cardiovascular disease (CVD) being the major cause of mortality in these patients. Despite a high burden of CKD among patients in low/middle-income countries (LMICs), evidence on the distribution of CVD among these patients is lacking. This review seeks to determine the prevalence, incidence and mortality risks of CVD in patients with CKD in LMICs. METHODS AND ANALYSIS: A systematic search of Medline, Scopus, Embase, Cumulative Index of Nursing and Allied Health and WHO Global Health Library databases for published studies reporting on the prevalence, incidence and associated mortality risk of CVD in CKD patients in LMICs will be conducted from 1 May 1987 to 1 July 2017 with no language restriction...
August 28, 2017: BMJ Open
Rashad S Barsoum
Geographical, ecological, and genetic factors result in many similarities among the six main countries of the African Sahara, including the epidemiology of kidney disease. With an average incidence of 182 and prevalence of 522 patients with end-stage kidney disease (ESKD) per million population, North Africa (NA) spends $650 million on dialysis and transplantation despite an estimated annual loss of 600,000 life years. The health burden of ESKD is not limited to its directly-related morbidity and mortality but affects even more significantly other body systems, particularly the cardiovascular system...
2016: Clinical Nephrology
Jean Jacques N Noubiap, Jashira Naidoo, Andre P Kengne
AIM: To determine the prevalence and incidence of diabetic nephropathy in Africa. METHODS: We performed a systematic narrative review of published literature following the MOOSE Guidelines for Meta-Analysis and Systematic Reviews of Observational Studies. We searched PubMed-MEDLINE for all articles published in English and French languages between January 1994 and July 2014 using a predefined strategy based on the combination of relevant terms and the names of each of the 54 African countries and African sub-regions to capture the largest number of studies, and hand-searched the reference lists of retrieved articles...
June 10, 2015: World Journal of Diabetes
Monika Kamkuemah, Richard Kaplan, Linda-Gail Bekker, Francesca Little, Landon Myer
OBJECTIVE: Long-term use of tenofovir disoproxil fumarate is associated with declines in glomerular function and chronic kidney disease in HIV-infected patients. We aimed to assess the prevalence and incidence of renal impairment in a primary care setting in sub-Saharan Africa. METHODS: We analysed data from 1092 HIV-infected patients initiating tenofovir at a primary care clinic in Cape Town, South Africa. Renal function was assessed for the first 12 months on ART by estimating glomerular filtration rate (eGFR) calculated using the Cockroft-Gault equation categorised into normal, mild, moderate and severe reduction in renal function based on values >90, 60-89, 30-59 and <30 ml/min/1...
April 2015: Tropical Medicine & International Health: TM & IH
O G Egbi, U H Okafor, K E Miebodei, B E Kasia, O E Kunle-Olowu, E I Unuigbe
INTRODUCTION: Chronic kidney disease (CKD) has become a public health problem with rising incidence and prevalence world-wide. Despite the fact that Sub-Saharan Africa, including Nigeria appears to be badly hit by this epidemic, there is a paucity of data on CKD prevalence in these regions and where data exists, they are mostly hospital-based. OBJECTIVES: The present study was carried out to determine the prevalence and correlates of CKD in an urban civil service population in Bayelsa State, Nigeria...
September 2014: Nigerian Journal of Clinical Practice
Rashad S Barsoum
North Africa (NAF) is composed of six countries located in the African Sahara, namely the Western Sahara, Morocco, Algeria, Tunisia, Libya, and Egypt. Common features between these countries include similar climate, ecology, population genetics, and the socioeconomic environment. This commonality reflects on the chronic kidney disease (CKD) profile in these countries. While there are some estimates on the epidemiology of end-stage kidney disease, that of earlier stages is unknown. Several national screening programs are currently addressing this issue, such as the EGIPT-CKD project in Egypt and the MAREMAR study in Morocco...
May 2013: Kidney International Supplements
Nomandla D Madala, Gertrude P Thusi, Alain G H Assounga, Saraladevi Naicker
BACKGROUND: Diabetes mellitus is the leading cause of end-stage renal disease (ESRD) globally. Diabetes and human immunodeficiency virus (HIV), both prevalent in South Africa, have not been reported as significant causes of ESRD. METHODS: We evaluated chronic kidney disease (CKD) and cardiovascular disease risk factors in a cross-sectional study of 302 patients (165 females/ 137 males) at a CKD clinic in rural northern KwaZulu-Natal. We included all CKD outpatient clinic attendees and excluded acute renal failure patients...
2014: BMC Nephrology
Ifeoma I Ulasi, Shay Tzur, Walter G Wasser, Revital Shemer, Etty Kruzel, Elena Feigin, Chinwuba K Ijoma, Obinna D Onodugo, Julius U Okoye, Ejikeme B Arodiwe, Ngozi A Ifebunandu, Chinwe J Chukwuka, Cajetan C Onyedum, Uchenna N Ijoma, Emmanuel Nna, Macaulay Onuigbo, Saharon Rosset, Karl Skorecki
BACKGROUND: Continental Africa is facing an epidemic of chronic kidney disease (CKD). APOL1 risk variants have been shown to be strongly associated with an increased risk for non-diabetic kidney disease including HIV nephropathy, primary non-monogenic focal and segmental glomerulosclerosis, and hypertension-attributed nephropathy among African ancestry populations in the USA. The world's highest frequencies of APOL1 risk alleles have been reported in West African nations, overlapping regions with a high incidence of CKD and hypertension...
2013: Nephron. Clinical Practice
Rafael Lozano, Mohsen Naghavi, Kyle Foreman, Stephen Lim, Kenji Shibuya, Victor Aboyans, Jerry Abraham, Timothy Adair, Rakesh Aggarwal, Stephanie Y Ahn, Miriam Alvarado, H Ross Anderson, Laurie M Anderson, Kathryn G Andrews, Charles Atkinson, Larry M Baddour, Suzanne Barker-Collo, David H Bartels, Michelle L Bell, Emelia J Benjamin, Derrick Bennett, Kavi Bhalla, Boris Bikbov, Aref Bin Abdulhak, Gretchen Birbeck, Fiona Blyth, Ian Bolliger, Soufiane Boufous, Chiara Bucello, Michael Burch, Peter Burney, Jonathan Carapetis, Honglei Chen, David Chou, Sumeet S Chugh, Luc E Coffeng, Steven D Colan, Samantha Colquhoun, K Ellicott Colson, John Condon, Myles D Connor, Leslie T Cooper, Matthew Corriere, Monica Cortinovis, Karen Courville de Vaccaro, William Couser, Benjamin C Cowie, Michael H Criqui, Marita Cross, Kaustubh C Dabhadkar, Nabila Dahodwala, Diego De Leo, Louisa Degenhardt, Allyne Delossantos, Julie Denenberg, Don C Des Jarlais, Samath D Dharmaratne, E Ray Dorsey, Tim Driscoll, Herbert Duber, Beth Ebel, Patricia J Erwin, Patricia Espindola, Majid Ezzati, Valery Feigin, Abraham D Flaxman, Mohammad H Forouzanfar, Francis Gerry R Fowkes, Richard Franklin, Marlene Fransen, Michael K Freeman, Sherine E Gabriel, Emmanuela Gakidou, Flavio Gaspari, Richard F Gillum, Diego Gonzalez-Medina, Yara A Halasa, Diana Haring, James E Harrison, Rasmus Havmoeller, Roderick J Hay, Bruno Hoen, Peter J Hotez, Damian Hoy, Kathryn H Jacobsen, Spencer L James, Rashmi Jasrasaria, Sudha Jayaraman, Nicole Johns, Ganesan Karthikeyan, Nicholas Kassebaum, Andre Keren, Jon-Paul Khoo, Lisa Marie Knowlton, Olive Kobusingye, Adofo Koranteng, Rita Krishnamurthi, Michael Lipnick, Steven E Lipshultz, Summer Lockett Ohno, Jacqueline Mabweijano, Michael F MacIntyre, Leslie Mallinger, Lyn March, Guy B Marks, Robin Marks, Akira Matsumori, Richard Matzopoulos, Bongani M Mayosi, John H McAnulty, Mary M McDermott, John McGrath, George A Mensah, Tony R Merriman, Catherine Michaud, Matthew Miller, Ted R Miller, Charles Mock, Ana Olga Mocumbi, Ali A Mokdad, Andrew Moran, Kim Mulholland, M Nathan Nair, Luigi Naldi, K M Venkat Narayan, Kiumarss Nasseri, Paul Norman, Martin O'Donnell, Saad B Omer, Katrina Ortblad, Richard Osborne, Doruk Ozgediz, Bishnu Pahari, Jeyaraj Durai Pandian, Andrea Panozo Rivero, Rogelio Perez Padilla, Fernando Perez-Ruiz, Norberto Perico, David Phillips, Kelsey Pierce, C Arden Pope, Esteban Porrini, Farshad Pourmalek, Murugesan Raju, Dharani Ranganathan, Jürgen T Rehm, David B Rein, Guiseppe Remuzzi, Frederick P Rivara, Thomas Roberts, Felipe Rodriguez De León, Lisa C Rosenfeld, Lesley Rushton, Ralph L Sacco, Joshua A Salomon, Uchechukwu Sampson, Ella Sanman, David C Schwebel, Maria Segui-Gomez, Donald S Shepard, David Singh, Jessica Singleton, Karen Sliwa, Emma Smith, Andrew Steer, Jennifer A Taylor, Bernadette Thomas, Imad M Tleyjeh, Jeffrey A Towbin, Thomas Truelsen, Eduardo A Undurraga, N Venketasubramanian, Lakshmi Vijayakumar, Theo Vos, Gregory R Wagner, Mengru Wang, Wenzhi Wang, Kerrianne Watt, Martin A Weinstock, Robert Weintraub, James D Wilkinson, Anthony D Woolf, Sarah Wulf, Pon-Hsiu Yeh, Paul Yip, Azadeh Zabetian, Zhi-Jie Zheng, Alan D Lopez, Christopher J L Murray, Mohammad A AlMazroa, Ziad A Memish
BACKGROUND: Reliable and timely information on the leading causes of death in populations, and how these are changing, is a crucial input into health policy debates. In the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010), we aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex. METHODS: We attempted to identify all available data on causes of death for 187 countries from 1980 to 2010 from vital registration, verbal autopsy, mortality surveillance, censuses, surveys, hospitals, police records, and mortuaries...
December 15, 2012: Lancet
S A Adebisi
BACKGROUND: Chronic kidney disease (CKD) is a global public health problem. The incidence and prevalence are increasing worldwide, while the outcomes remain poor and treatment cost high. Unfortunately, CKD in Sub-Sahara Africa is usually diagnosed late and supported with limited treatment facility. OBJECTIVE: This study aimed at filling the gap created by late diagnosis by assessing utility of estimated glomerular filtration rate (eGFR) in Nigerians and possibly proposing routine reporting of eGFR for earlier diagnosis of CKD...
November 2011: West African Journal of Medicine
M O Odubanjo, A O Oluwasola, S Kadiri
The incidence of CKD (Chronic kidney disease) in Nigeria has been shown by various studies to range between 1.6 and 12.4%. We have shown that the burden of renal disease in Nigeria is probably significantly higher than any previous study on end-stage renal disease (ESRD) has documented, as most studies are hospital-based and fail to include the many patients who do not have access to hospital care. The increased prevalence of ESRD among blacks in the United States and South Africa compared with other races also suggests that ESRD may be more prevalent in Africa than in the United States and other developed nations...
September 2011: International Urology and Nephrology
Mary Carter, John Callegari
To date, no sustainable treatment program exists for kidney failure in countries in sub-Saharan Africa. No data are available on the incidence, prevalence or cause of chronic kidney disease (CKD). The world's focus has been on treating 'priority diseases' as defined by the United Nations Millennium Project and the World Health Organization because of their high mortality rates. This is understandable because HIV/AIDS, tuberculosis, diarrheal diseases and malaria claim majority of the lives; however, in many cases, the mortality is due to acute renal failure (ARF) as a consequence of the progression of these diseases...
2007: Journal of Hospital Marketing & Public Relations
Fatiu A Arogundade, Rashad S Barsoum
The upsurge in incidence and prevalence of chronic kidney disease (CKD) in both developed and developing nations has necessitated a renewed interest in global CKD prevention because it is now regarded as a public health threat. Although CKD management is consuming a huge proportion of health care finances in developed countries, it is contributing significantly to morbidity, mortality, and decreased life expectancy in developing ones. CKD epidemiological characteristics in Sub-Saharan Africa (SSA) are strikingly different from those observed in other regions...
March 2008: American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"